| Literature DB >> 26973528 |
Zhiming Li1, Huinuan Lin2, Long Gu2, Jingwen Gao2, Chi-Meng Tzeng3.
Abstract
Cistanche species, known as Rou Cong-Rong in Chinese, are an endangered wild species and are mainly distributed in the arid lands and warm deserts of northwestern China. Within Traditional Chinese Medicine (TCM), Herba Cistanche is applied as a tonic and/or in a formula for chronic renal disease, impotence, female infertility, morbid leucorrhea, profuse metrorrhagia, and senile constipation. The chemical constituents of Herba Cistanche mainly consist of volatile oils, non-volatile phenylethanoid glycosides (PhGs), iridoids, lignans, alditols, oligosaccharides, and polysaccharides. There have been an increasing number of studies focusing on its bio-activities, including antioxidation, neuroprotection, and antiaging. The objective of this review is to introduce this herb to the world. Its taxonomy, distribution, and corresponding biological functions and molecular mechanisms are addressed in this review.Entities:
Keywords: Cistanche species; Herba Cistanche; aphrodisiac effect; immune-boosting effect; improvement of brain function; phenylethanoid glycosides
Year: 2016 PMID: 26973528 PMCID: PMC4771771 DOI: 10.3389/fphar.2016.00041
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Pharmaceutical effects of the active components from Herba Cistanche.
| Active ingredient | Functions | Related diseases | Pathways | Research model | Reference |
|---|---|---|---|---|---|
| Phenylethanoid glycosides (PhGs) | Antioxidation, neuroprotection | PD | Preventing MPP+-induced apoptosis | Rat cerebella granule neurons (CGNs) | |
| Neuroprotection, enhancing sexual function | – | – | Mice | ||
| Enhancing immunity | – | Increasing T lymphocyte transformation | Mouse T cells | ||
| Antioxidation, hepatoprotection | – | XOD inhibition | Rat liver microsome | ||
| Neuroprotection | AD | – | Clinical trial | ||
| Antioxidation | – | Repairing OH⋅-induced DNA damage | Spin trapping | ||
| Neuroprotection | AD | Increasing bax expression | Aβ 25-35-induced AD PC12 model | ||
| Echinacoside | Neuroprotection | PD | – | Mouse MPTP model | |
| Neuroprotection | – | Inhibition of caspase-3 activity, increase Bcl2 expression | SHSY5Y (human neuroblastoma) cells | ||
| Endothelium-dependent relaxation | Vascular diseases, sexual dysfunction | NO-cGMP pathways | Rat thoracic aortic rings | ||
| Acteoside | Neuroprotection | – | Preventing MPP+-induced apoptosis | Rat CGNs | |
| Anti-allergy | Type I allergy | Ca/NFAT and JNK MAPK | KU812 (human basophilic) cells | ||
| Tubuloside B | Neuroprotection | Neurodegenerative diseases | Preventing MPP+-induced apoptosis | Rat PC12 neuronal cells | |
| Neuroprotection | Neurodegenerative diseases | Maintain mitochondria function, decrease concentration of free intracellular calcium and inhibit caspase-3 activity | SHSY5Y (human neuroblastoma) cells |